Medications for Osteoporosis Postmenopausal
34 results
Abigale (estradiol and norethindrone acetate)
(estradiol and norethindrone acetate)Xiromed LLC
Usage: Abigale and Abigale Lo are indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as the prevention of postmenopausal osteoporosis, particularly in women at significant risk. Topical products and non-estrogen medications should be considered first for certain indications.
Alendronate (alendronate sodium tablet)
(Alendronate sodium tablet)Marlex Pharmaceuticals Inc
Usage: Alendronate sodium is indicated for treating osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, preventing postmenopausal osteoporosis, treating glucocorticoid-induced osteoporosis, and managing Paget's disease of bone in symptomatic patients or those at risk for complications. Reinforcement of therapy need is recommended periodically.
Alendronate sodium (alendronate sodium)
(Alendronate Sodium)A-S Medication Solutions
Usage: Alendronate sodium tablets are indicated for treating and preventing osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, treating glucocorticoid-induced osteoporosis, and managing Paget's disease of bone. Periodic reevaluation of therapy necessity is recommended.
Calcitonin salmon (calcitonin salmon)
(Calcitonin Salmon)Bryant Ranch Prepack
Usage: Calcitonin Salmon (synthetic origin) Nasal Spray is indicated for treating postmenopausal osteoporosis in women over five years postmenopause. It is meant for patients unable to use other treatments. There is no demonstrated efficacy for fracture reduction, and the need for ongoing therapy should be periodically reassessed.
Calcitonin salmon (calcitonin salmon)
(CALCITONIN SALMON)Cipla USA Inc.
Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget's disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in women over five years postmenopause. It is recommended for patients unable to use alternative treatments, and the need for continued therapy should be periodically reassessed due to potential malignancy risk.
Climara (estradiol)
(Estradiol)Bayer HealthCare Pharmaceuticals Inc.
Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.
Climara pro (estradiol and levonorgestrel)
(Estradiol and Levonorgestrel)Bayer HealthCare Pharmaceuticals Inc.
Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause and for the prevention of postmenopausal osteoporosis, with caution to consider non-estrogen alternatives in low-risk women.
Duavee (conjugated estrogens/bazedoxifene)
(conjugated estrogens/bazedoxifene)Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Usage: DUAVEE is indicated for women with a uterus to treat moderate to severe menopausal vasomotor symptoms and to prevent postmenopausal osteoporosis. Treatment duration should be minimal and reconsidered periodically, focusing on women at significant risk of osteoporosis.
Estradiol (estradiol)
(estradiol)Preferred Pharmaceuticals Inc.
Usage: Estradiol transdermal system is indicated for treating moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from various causes, and preventing postmenopausal osteoporosis, ideally after evaluating other treatment options first.
Estradiol transdermal system (estradiol)
(Estradiol)Sandoz Inc
Usage: The Estradiol Transdermal System is indicated for treating moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from various causes, and prevention of postmenopausal osteoporosis, with specific limitations for certain conditions.